Aggressive prolactinomas: how to manage?
L Hélène, MD Ilie, R Gérald - Pituitary, 2020 - search.proquest.com
Purpose Aggressive prolactinomas are defined as radiologically invasive tumors which
cannot be cured by surgery, and that have an unusually rapid rate of tumor growth despite …
cannot be cured by surgery, and that have an unusually rapid rate of tumor growth despite …
Aggressive prolactinomas responsive to temozolomide treatment: Report of two cases
Refractory aggressive prolactinomas are detected after the unresponsiveness to
conventional therapies. We report two cases that underwent temozolomide treatment and …
conventional therapies. We report two cases that underwent temozolomide treatment and …
The treatment of aggressive prolactinomas with everolimus
AL Lin, EB Geer, N Lala, G Page-Wilson, R Magge… - Pituitary, 2023 - Springer
Introduction Aggressive prolactinomas are life-limiting tumors without a standard of care
treatment option after the oral alkylator, temozolomide, fails to provide tumor control …
treatment option after the oral alkylator, temozolomide, fails to provide tumor control …
Early recognition and initiation of temozolomide chemotherapy for refractory, invasive pituitary macroprolactinoma with long-term sustained remission
G Barkhoudarian, SK Palejwala, R Ogunbameru… - World Neurosurgery, 2018 - Elsevier
Objective Invasive, medically refractory, and multiply recurrent pituitary adenomas pose a
rare, but nevertheless significant, challenge for conventional management modalities …
rare, but nevertheless significant, challenge for conventional management modalities …
[HTML][HTML] Treatment of aggressive prolactin-secreting pituitary adenomas with adjuvant temozolomide chemotherapy: a review
Most prolactin-secreting pituitary adenomas demonstrate slow growth and are effectively
managed with medical/surgical therapy. Rarely, these tumors can behave aggressively with …
managed with medical/surgical therapy. Rarely, these tumors can behave aggressively with …
Therapy of aggressive pituitary tumors
A Colao, LFS Grasso, R Pivonello… - Expert opinion on …, 2011 - Taylor & Francis
Introduction: Aggressive tumors of the pituitary gland are classically defined as pituitary
tumors with a massive invasion of the surrounding anatomical structures and rapid growth …
tumors with a massive invasion of the surrounding anatomical structures and rapid growth …
Therapy of endocrine disease: the challenges in managing giant prolactinomas
D Maiter, E Delgrange - European Journal of Endocrinology, 2014 - academic.oup.com
Giant prolactinomas are rare tumours, representing only 2–3% of all prolactin (PRL)-
secreting tumours and raising special diagnostic and therapeutic challenges. Based on …
secreting tumours and raising special diagnostic and therapeutic challenges. Based on …
Current management of prolactinomas
P Nomikos, M Buchfelder, R Fahlbusch - Journal of neuro-oncology, 2001 - Springer
Prolactinomas constitute the largest group of pituitary adenomas in autopsy series.
However, their relative incidence in recent surgical series is much less impressive since …
However, their relative incidence in recent surgical series is much less impressive since …
Temozolomide cytoreductive treatment in a giant cabergoline-resistant prolactin-secreting pituitary neuroendocrine tumor
Dopamine agonists (DAs, especially cabergoline) are recommended as first-line treatment
in patients with prolactin-secreting pituitary adenomas, to reduce hormone secretion and …
in patients with prolactin-secreting pituitary adenomas, to reduce hormone secretion and …